Article Archives

2013, Volume 23, Number 1

DNA-Based Non-Invasive Prenatal Testing (NIPT) for Fetal Aneuploidy
William G. Finn, M.D.
Editorial: Pre-Test Probability Matters - A Comment Regarding “Shotgun” Testing
William G. Finn, M.D.

2012, Volume 22, Number 5
Ethylene Glycol
By Ntei Abudu, Ph.D. and Richard S. Bak, Ph.D.
Editorial: Your Health — Nonpharmacologic Management of Gout
By Danny Wiedbrauk, Ph.D.

2012, Volume 22, Number 4
Fourth Generation HIV Testing and New Diagnostic Algorithms for Detecting HIV Infection
William G. Finn, M.D.
Editorial: Limitations of Virus Culture
Danny L. Wiedbrauk, Ph.D.

2012, Volume 22, Number 3
Immunophenotyping Utilizing 6 Color Flow Cytometry
John L. Carey, M.D.
Editorial: Harnessing the Power of Multicolor Flow Cytometry
William G. Finn, M.D.

2011, Volume 22, Number 2
Pain Management
Ntei Abudu, PhD
Warde's New Medical Director: Dr. William G. Finn
David F. Keren

2011, Volume 22, Number 1
Detection of Prenatal Drug Abuse in Meconium
Ntei Abudu, PhD
Editorial: Sample is key for a Correct Aldosterone-Renin Ratio (ALRR)
Sharon O’Neal and David F. Keren
FAST FACTS: Pertussis Testing

2010, Volume 21, Number 3
Norovirus Infection
Danny L. Wiedbrauk, Ph.D.
FAST FACTS: A New Warde Report Feature
WML_FastFacts_Norovirus-Testing.pdf
WML_FastFacts_Herpes-Simplex-Serologies.pdf
WML_FastFacts_Influenza-Testing.pdf
Danny L. Wiedbrauk, Ph.D.

2010, Volume 21, Number 2
Laboratory Evaluation for Monoclonal Gammopathies: MGUS to Myeloma
David F. Keren, M.D

2010, Volume 21, Number 1
Celiac Disease Panel: IgA and IgG anti-Tissue Transglutaminase/ IgA and IgG anti-Deamidated Gliadin
David F. Keren, M.D
Decreasing Health Care Costs by Eliminating the Over-Utilization of Flow Cytometry
John L. Carey, III, M.D. and David F. Keren M.D.

2009, Volume 20, Number 3
Screening Methods for the Diagnosis of Cushing's Syndrome
Ntei Abudu, PhD, Director of Toxicology, Warde Medical Laboratory
The New Standard for Precise Quantitative Assays: Liquid Chromatography-tandem mass spectrometry (LC-MS/MS)
David F. Keren M.D.

2009, Volume 20, Number 2
New Concepts in Prenatal Testing: Sequential Integrated Screening
David F. Keren M.D.
Update — Swine Origin Influenza A (H1N1)
Danny L. Wiedbrauk, Ph.D., Scientific Director, Virology and Molecular Biology
CSF Culture Change
Danny L. Wiedbrauk, Ph.D., Scientific Director, Virology and Molecular Biology
HIV-1 Qualitative Assay vs. HIV Proviral DNA Assay
Danny L. Wiedbrauk, Ph.D., Scientific Director, Virology and Molecular Biology

2009, Volume 20, Number 1
Update: Flow Cytometric Immunophenotyping of Hematolymphoid Neoplasia
By John L. Carey, M.D., Director, Flow Cytometry
Ensuring Quality Results for Your Patient
David F. Keren M.D.

2008, Volume 19, Number 3
Ethyl Glucuronide: A Sensitive Marker for Alcohol Consumption
By Ntei Abudu, PhD.
Potential for False Positive Antineutrophil Cytoplasmic Antibody (ANCA) Testing
David F. Keren M.D.

2008, Volume 19, Number 2
The Prenatal Screen that I Recommend for My Daughter—The Full Integrated Screen
By David F. Keren, M.D.
Changes in Human Papillomavirus Testing
By Danny L Wiedbrauk, PhD

2008, Volume 19, Number 1
Vitamin B1 Thiamine
By Richard S. Bak, Ph.D.
Western Blots are a Confirmation Test, Not a Screen for Human Immunodeficiency Virus (HIV) Infection
By David F. Keren, M.D.

2007, Volume 18, Number 2
Measuring Serum Free Light Chains (FLC) Improves Diagnosis and Prognosis for Patients with Monclonal Gammopathies
By David F. Keren, M.D.
A Negative RAST Becomes Positive. What to do?
By David F. Keren, M.D.

2007, Volume 18, Number 1
Nucleic Acid Testing for Chlamydia trachomatis and Neisseria gonorrhoeae
By Danny L. Wiedbrauk, Ph.D.
Changes in Virus Detection Protocols
By Danny L. Wiedbrauk, Ph.D.
Lipid Screening for Coronary Heart Disease
By David F. Keren, M.D.

2006, Volume 17, Number 2
Clinical Cytogenetics and Molecular Cytogenetics
By Steven L. Gersen, Ph.D. Managing Director / Director, Cytogenetics and FISH Laboratories Shelton, CT
Interpreting the New Syphilis Screening Tests
By David F. Keren, M.D.

2006, Volume 17, Number 1
Vitamin D and Metabolites
By Richard S. Bak, Ph.D.
PCR Testing for Herpes Simplex Virus and Varicella-Zoster Virus
By Danny L. Wiedbrauk Ph.D. Scientific Director, Virology and Molecular Biology

2005, Volume 16, Number 2
Testing for Increased Susceptibility to Clotting. What? When? Why?
By John D. Schaldenbrand, MD
Editorial: Factor V Leiden NOT Factor V Activity, Prothrombin G20210A NOT Factor II Activity
By David F. Keren, MD and John D. Schaldenbrand, MD

2005, Volume 16, Number 1
Serum Free Light Chain Assay in Diagnosis and Monitoring of Multiple Myeloma
By D.E. Smith, A.R. Bradwell, G.P. Mead, H.D. Carr-Smith
Editorial: High Sensitive C-Reactive Protein (hs-CRP) in evaluating risk of Heart Disease and Stroke
By David F. Keren, MD

2004, Volume 15, Number 2
Plasma Free Metanephrine and the Laboratory Evaluation
for Pheochromocytoma

By David F. Keren, M.D.
Salivary Cortisol and the Laboratory Evaluation
of Cushing's Syndrome

By David F. Keren, M.D.
Editorial: Specimens that are QNS for HPV Testing
By Danny L. Wiedbrauk, Ph.D.
Scientific Director, Virology and Molecular Biology

2004, Volume 15, Number 1
First Trimester Testing or Integrated Screening Offered
Through Warde Medical Laboratory
By David F. Keren, M.D.
Editorial: Improved Sensitivity of CSF Oligoclonal Bands in the Diagnosis of Multiple Sclerosis
By David F. Keren, M.D.

2003, Volume 14, Number 3
Clinical Evaluation of Hemoglobinopathies: Part II Structural Changes
By David F. Keren, M.D.
Editorial: Co-tenancy and the Laboratory; Now More Than Ever?
By Dennis Hodges

2003, Volume 14, Number 2
Clinical Evaluation of Hemoglobinopathies: Part 1 Thalassemia
By David F. Keren, M.D.
Editorial: Testing Cytyc® ThinPrep® Specimens for Chlamydia trachomatis and Neisseria gonorrhoeae: Problems in Paradise?
By D.L. Wiedbrauk, Ph.D.

2003, Volume 14, Number 1
Frequently Asked Questions about
Human Papillomavirus (HPV) Testing)

By D.L. Wiedbrauk, Ph.D.
Celiac Disease Serology
By Richard S. Bak, Ph.D.
Editorial: Nitroprusside

2002, Volume 13, Number 3
Prenatal Screening Update:
The QUAD test and Smith-Lemli-Opitz Syndrome (SLOS)

By David F. Keren, M.D.
Editorial: Prenatal Information That We Need
Fact Sheet: West Nile Virus

2002, Volume 13, Number 2
Heparin-Induced Thrombocytopenia (HIT): A Difficult Diagnosis with Potential Catastrophic Consequences
By Douglas A. Triplett, M.D., F.A.C.P., F.C.A.P.
Editorial: What does a positive IgM anti-HSV mean?

2002, Volume 13, Number 1
Virology Testing Update
D.L. Wiedbrauk, Ph.D.
Editorial: Alzheimer's Disease Testing

2001, Volume 12, Number 3
New Standard for Prenatal Screening -The Quad Test
David F. Keren, M.D.
Editorial: Assessment of the Risk of Coronary Heart Disease

2001, Volume 12, Number 2
Assessment of Fetal Lung Maturity
Richard S. Bak, Ph.D.
Editorial: Fluorescent Polarization Test (FLM):the New Test for Assessing Fetal Lung Maturity

2001, Volume 12, Number 1
Toxicology Update
Robert M. Johnson, Ph.D., Patrick Ng, Ph.D.
Editorial: What's New at Warde

2000, Volume 11, Number 2
Guidelines for the Clinical Use of ANA and Related Specific Autoantibody Testing
David F. Keren, M.D.
Editorial: What is High-Sensitivity CRP?

2000, Volume 11, Number 1
Anticardiolipin Antibodies (ACA):
Antigenic Targets and Pathophysiology

Douglas A. Triplett, M.D.
Editorial:The Quad Test

1999, Volume 10, Number 3
Clinical Genetic Testing
Kristin G. Monaghan, Ph. D., FACMG
Daniel L. Van Dyke, Ph. D., FACMG
Anne Wiktor, BS, CLSp (CG)
Guest Editorial: Fallout from the Human Genome Project

1999, Volume 10, Number 2
Vitamins, Hormones, and Bones:
Have You Had Your Vitamins Today?

Gordon D MacFarlane, Ph. D., Senior Scientist, DiaSorin Inc.
Editorial: Clinical Use of Vitamin D Assays

1999, Volume 10, Number 1
Consensus Guidelines for Evaluating Monoclonal Gammopathies
David F. Keren, M.D.
Editorial: Call us With Your Questions About New Tests

1998, Volume 9, Number 3
Thrombophilia (Hypercoagulable States)
Douglas A. Triplett, M.D., F.A.C.P., F.C.A.P.
Editorial: When to Test for Genetically Related Diseases

1998, Volume 9, Number 1
Point-of-Care Testing: A Review
Victor Hruszczyk, M.S.

Warde
Medical
Laboratory